🎬 Review of the FFRD symposim on the Microbiota “live” !
Experience the FFRD symposium on Microbiota which took place during the SFD Congress – which occured at the Palais des Congrès in Paris from 1st…
"Promoting and supporting research on diabetes
and metabolic diseases"
For the advancement of diabetes research
‼️ DISCOVER THE 2025 WINNERS ‼️
The Scientific Council of the Fondation Francophone pour la Recherche sur le Diabète – FFRD – has made its decision! 2025 marks its 13th call for projects with nearly 40 Francophone applicants…
🚦 Since 2013, it means a total of:
🙏 The FFRD thanks its faithful partners and donors and is proud to dedicate more than 80% of its expenditures to diabetes research in Francophonie !
📆 Openning of the next FFRD call for projects in February 2026…
🎯 Promoting and supporting diabetes research, its mechanisms, prevention, managemnet, comorbidities and complications…
For the advancement of diabetes research and TO REDUCE THE BURDEN OF THE DISEASE 🩸
Experience the FFRD symposium on Microbiota which took place during the SFD Congress – which occured at the Palais des Congrès in Paris from 1st…
Finalization of the calendar for the Board of Directors
Overview of 2025 and projections for 2026
Validation of the 2026 calendar
The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.
The FFRD supports clinical, basic, and translational research.
The supported basic research projects address major themes of type 1 and type 2 diabetes
covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.
The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes
and often involve large multicenter cohort studies.
Since 2013, the Foundation has been: